Acenocoumarol or warfarin: Which is the clinician’s ally?

Rao, Karthik N and Patil, Navin and Avinash, A and Hande, Manjunath H and Kunder, Sushil Kiran and Rao, Raghavendra (2016) Acenocoumarol or warfarin: Which is the clinician’s ally? Asian Journal of Pharmaceutical and Clinical Research, 9 (2). pp. 4-5. ISSN 0974-2441

[img] PDF
327.pdf - Published Version
Restricted to Registered users only

Download (309kB) | Request a copy


Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

Item Type: Article
Uncontrolled Keywords: Thrombosis; bleeding; antiphospholipid antibody syndrome; anticoagulant; International normalized ratio.
Subjects: Medicine > KMC Manipal > Medicine
Medicine > KMC Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 10 Mar 2016 10:27
Last Modified: 10 Mar 2016 10:27

Actions (login required)

View Item View Item